Value Assessment and Health Outcomes Research Postdoctoral Fellowship Grant

Value Assessment and Health Outcomes Research Postdoctoral Fellowship Grant

Status: ACTIVE
Funder: Pharmaceutical Research And Manufacturers Of America Fnd Inc (PhRMA)
Amount: Up to US $120,000
Last Updated: August 15, 2025

Summary

The Value Assessment and Health Outcomes Research Postdoctoral Fellowship, funded by the PhRMA Foundation, offers a $60,000 stipend annually for up to two years. This fellowship supports researchers, both U.S. and non-U.S. citizens, engaged in innovative studies aimed at evaluating the effectiveness and value of healthcare interventions. Applicants must be within five years of postdoctoral study and hold a relevant doctoral degree. This opportunity fosters collaboration and patient engagement in health outcomes research.

Overview

NOTE: Application submission and reference letters of support are due by the deadline. PhRMA Foundation Mission The PhRMA Foundation is a 501(c)(3) nonprofit organization that fosters biopharmaceutical innovation and value-driven health care by investing in the frontiers of research. The Foundation catalyzes the careers of promising researchers through competitive, peer-reviewed grants and fellowships in the fields of drug delivery, drug discovery, translational medicine, and value assessment and health outcomes research. Vision A healthier world where all people have access to innovative, life-changing medicines. Values Integrity: We strive to be scientifically independent and evidence-based in our decision-making.Innovation: We invest in cutting-edge research and ideas that will improve patient health.Collaboration: We support collaborative research efforts that are diverse and inclusive. Value Assessment and Health Outcomes Research Postdoctoral Fellowship The PhRMA Foundation’s Postdoctoral Fellowship in Value Assessment-Health Outcomes Research (VA-HOR) supports individuals (U.S. and non-U.S. citizens) engaged in a multidisciplinary, collaborative research training program at an accredited U.S. university that will extend their credentials in value assessment and/or health outcomes research. Program Goals The PhRMA Foundation seeks research proposals that investigate challenges and potential solutions related to evaluating the delivery, safe use, effectiveness, and value (clinical, patient-centered, and economic) of medicines and other health care interventions. Proposals could be empirical analyses or studies addressing methodological aspects of the following areas: Clinical and economic outcomes using real-world data and analytic tools Clinical outcomes assessments Patient-reported and/or patient-centered outcomes, especially for diverse or underserved populations Patient health preferences research Evaluation and outcomes assessments focused on health equity or unmet need Innovative methods for measuring and reporting novel value elements (e.g., clinical, cost, health preference) from different stakeholder perspectives Development of innovative decision and communication tools Patient- and equity-centered value assessment frameworks Health policy research Proposals should incorporate patient engagement at an appropriate level to be responsive. Funding The PhRMA Foundation Postdoctoral Fellowship in Value Assessment-Health Outcomes Research provides $60,000 in stipend support per year for 12, 18, or 24 months. Funding is conditional upon the awardee’s continued employment with the university in the postdoctoral program, which will be assessed on a quarterly basis prior to payment. Payments will be made directly to the university on behalf of the awardee, with the understanding the university will administer the funds.This award is intended solely as a stipend and may not be used otherwise. An individual may not simultaneously hold another funding mechanism providing stipend support while the PhRMA Foundation postdoctoral fellowship is active. If necessary, the university may supplement the award to a level that is consistent with other postdoctoral fellowships it currently offers.Funding may begin as early as July 1, 2024, or on the first day of any month thereafter, up to and including December 1, 2024. Unspent funds are to be returned to the PhRMA Foundation.Any changes to the proposed project must be approved by the PhRMA Foundation. These funds are non-transferable.

Eligibility

You can learn more about this opportunity by visiting the funder's website. Applicants (U.S. and non-U.S. citizens) must currently be in a PhD and/or MS degree-granting accredited U.S. university.Applicants must have a firm commitment from a research supervisor or sponsor at their university.Applicants must hold a PhD, PharmD, MD or appropriate terminal research doctorate. If you do not hold one at the time of application submission, please state in your extended letter when you expect to receive it, as it must be received before funding can begin. Applicants must be within their first five years of postdoctoral study at the time of award activation.Applicants who have taken a formal leave of absence from their education (e.g., parenting of a child, childbirth, long-term care of a parent/spouse/child/dependent, personal health issues) that puts them outside of the eligibility time frame can reach out to PhRMA Foundation staff ahead of their application submission to determine their eligibility. The Foundation requires confirmation from the school that such leave was formally taken.Applicants currently funded on an institutional training grant (e.g., NIH TL1, T32, T90, or T35 awards or a nonprofit/professional society equivalent) may apply if they state they will forgo the institutional training slot if funded by a PhRMA Foundation postdoctoral award.

Ineligibility

You are not eligible if your doctoral degree was granted before January 1, 2023.The Foundation will not consider multiple applications for the same or similar efforts on the same project. If multiple applicants are submitting proposed efforts on the same project, the efforts must be separate activities and not duplicative. PhRMA Foundation funds may not be used for tuition, fringe benefits, or indirect costs to the university.Applicants are ineligible if they are the recipient of an NIH K99/R00 award or NIH-F award.